FIELD: pharmaceutical industry.
SUBSTANCE: drug composition includes antihistamine agent as active principle, in particular 1-(p-chlorophenyl)-1-(pyrid-2-yl)-3-N,N-dimethylpropylamine or pharmaceutically acceptable salt thereof, and pharmaceutically acceptable carrier including microcrystalline cellulose, lactose, crospovidone, and magnesium stearate.
EFFECT: optimized bioavailability, increased storage stability, and improved organoleptic properties.
6 cl, 5 ex
